Altogether, these data indicated that the HBP may coordinate with the glycolytic pathway to regulate CD133 expression in hepatoma cell lines, thus maintaining the CSC-like phenotype (Lin et al., 2016). The gene discussed is PROM1; the disease is hepatocellular carcinoma.